Production (Stage)
The Oncology Institute, Inc.
TOI
$3.02
$0.031.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.74M | 49.67M | 47.40M | 46.36M | 65.83M |
| Total Receivables | 49.67M | 48.68M | 54.86M | 54.37M | 59.13M |
| Inventory | 12.31M | 10.04M | 10.11M | 11.32M | 11.55M |
| Prepaid Expenses | 5.11M | 4.03M | 4.06M | 4.16M | 4.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 106.82M | 112.42M | 116.43M | 116.21M | 141.19M |
|
|
|||||
| Total Current Assets | 106.82M | 112.42M | 116.43M | 116.21M | 141.19M |
| Net Property, Plant & Equipment | 35.33M | 37.67M | 39.36M | 39.22M | 38.41M |
| Long-term Investments | 7.23M | 7.23M | 7.23M | 7.23M | 7.23M |
| Goodwill | 7.23M | 7.23M | 7.23M | 7.23M | 7.23M |
| Total Other Intangibles | 14.04M | 14.81M | 15.58M | 16.36M | 17.13M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 591.00K | 589.00K | 588.00K | 582.00K | 568.00K |
| Total Assets | 164.00M | 172.72M | 179.18M | 179.60M | 204.53M |
|
|
|||||
| Total Accounts Payable | 29.29M | 24.32M | 24.57M | 15.75M | 21.02M |
| Total Accrued Expenses | 8.38M | 12.98M | 8.44M | 6.28M | 8.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.85M | 6.84M | 6.79M | 6.56M | 6.43M |
| Total Finance Division Other Current Liabilities | 15.02M | 8.08M | 6.96M | 6.51M | 10.26M |
| Total Other Current Liabilities | 15.02M | 8.08M | 6.96M | 6.51M | 10.26M |
| Total Current Liabilities | 59.54M | 52.22M | 46.76M | 35.10M | 45.77M |
|
|
|||||
| Total Current Liabilities | 59.54M | 52.22M | 46.76M | 35.10M | 45.77M |
| Long-Term Debt | 73.89M | 93.13M | 91.54M | 89.95M | 88.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.65M | 23.29M | 24.74M | 24.62M | 25.15M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.85M | 495.00K | 671.00K | 728.00K | 3.93M |
| Total Liabilities | 158.93M | 169.13M | 163.70M | 150.40M | 163.24M |
|
|
|||||
| Common Stock & APIC | 236.49M | 215.42M | 214.13M | 211.74M | 208.35M |
| Retained Earnings | -230.40M | -210.81M | -197.63M | -181.52M | -166.04M |
| Treasury Stock & Other | -1.02M | -1.02M | -1.02M | -1.02M | -1.02M |
| Total Common Equity | 5.07M | 3.59M | 15.48M | 29.21M | 41.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.07M | 3.59M | 15.48M | 29.21M | 41.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.07M | 3.59M | 15.48M | 29.21M | 41.30M |
|
|
|||||